Signify Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 139.8 million compared to USD 199.2 million a year ago. Net loss was USD 159 million compared to net income of USD 20.2 million a year ago. Basic loss per share from continuing operations was USD 0.9 compared to basic earnings per share from continuing operations of USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.9 compared to diluted earnings per share from continuing operations of USD 0.12 a year ago.
For the nine months, sales was USD 602.5 million compared to USD 592 million a year ago. Net loss was USD 540.4 million compared to USD 3 million a year ago. Basic loss per share from continuing operations was USD 3.08 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 3.08 compared to USD 0.02 a year ago.